Pages that link to "Q57105182"

The following pages link to Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines (Q57105182):

Displaying 41 items.

• Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs (Q28080092) (← links)
• Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine. (Q30379877) (← links)
• Identification of Molecular Signatures from Different Vaccine Adjuvants in Chicken by Integrative Analysis of Microarray Data (Q31054454) (← links)
• Long-term changes of serum chemokine levels in vaccinated military personnel (Q33257138) (← links)
• Dietary germanium biotite supplementation enhances the induction of antibody responses to foot-and-mouth disease virus vaccine in pigs (Q34258615) (← links)
• Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity (Q34366399) (← links)
• Supplementation of dietary germanium biotite enhances induction of the immune responses by foot-and-mouth disease vaccine in cattle (Q34539568) (← links)
• Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development (Q34571663) (← links)
• Porcine gammadelta T cells: possible roles on the innate and adaptive immune responses following virus infection. (Q36484045) (← links)
• Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review (Q37224088) (← links)
• Evaluation of immune responses of stabilised SAT2 antigens of foot-and-mouth disease in cattle. (Q39442126) (← links)
• Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle (Q40113607) (← links)
• A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination (Q41099886) (← links)
• Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle (Q41663972) (← links)
• Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection (Q43028375) (← links)
• Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus (Q45351178) (← links)
• No between-pen transmission of foot-and-mouth disease virus in vaccinated pigs (Q45376550) (← links)
• High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus (Q45396763) (← links)
• Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge. (Q45404938) (← links)
• Immunogenicity of peptides of measles virus origin and influence of adjuvants (Q45424364) (← links)
• Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep (Q45669551) (← links)
• Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH. (Q46512462) (← links)
• IL-6 production following vaccination in pigs--an additional immune response parameter for assessing FMD vaccine efficacy? (Q46522023) (← links)
• Comparison of mouse and rabbit model for the assessment of strong PGM-containing oil-based adjuvants (Q46904920) (← links)
• Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. (Q48041390) (← links)
• Microvascular endothelial cells play potential immunoregulatory roles in the immune response to foot‐and‐mouth disease vaccines (Q54377073) (← links)
• Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. (Q54568153) (← links)
• Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. (Q54646040) (← links)
• Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep (Q56574998) (← links)
• Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve (Q57098605) (← links)
• Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits (Q63441135) (← links)
• Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model (Q79329188) (← links)
• Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV (Q80205526) (← links)
• Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O (Q81194749) (← links)
• Montanide™ ISA 71 VG adjuvant enhances antibody and cell-mediated immune responses to profilin subunit antigen vaccination and promotes protection against Eimeria acervulina and Eimeria tenella (Q84782019) (← links)
• The interference effect of maternally-derived antibodies on the serological performance of pigs immunized with a foot-and-mouth disease oil emulsion vaccine (Q92355480) (← links)
• Immunogenicity of imported foot-and-mouth vaccines in different species in Mongolia (Q92573073) (← links)
• Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory (Q92574362) (← links)
• Web-based forecasting system for the airborne spread of livestock infectious disease using computational fluid dynamics (Q94502297) (← links)
• The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine (Q94539244) (← links)
• Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects (Q98953662) (← links)